Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro costs vary by dose and provider, but as a privately prescribed weight-loss medicine in the UK, typical monthly prices have ranged roughly £149–£375 since Eli Lilly raised its list price in September 2025. That figure should be your starting point when budgeting — though what it actually covers depends entirely on who you buy it from. Mounjaro is a prescription-only medicine, which means a prescriber must assess your suitability before any treatment is dispensed. The price you pay should always include that clinical oversight, not just the pen.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Eli Lilly raised Mounjaro's UK list price on 1 September 2025. Before that increase, the highest-dose pen sat around £122; it has since risen to around £330 at list price. Private providers set their own retail figures above that, so the range across the market is broad, roughly £149 at the lower doses up to around £375 per four-week pen at the highest strengths. These figures are widely reported and worth knowing, but they are a starting point, not a full picture.
Mounjaro is dispensed one pen at a time, and each pen contains four weekly doses. So when you see a monthly price quoted anywhere, it refers to a single pen covering one four-week cycle. If you want to understand what a full course might look like financially, our breakdown of monthly Mounjaro costs works through this in detail.
One practical check worth doing in under a minute: visit the GPhC pharmacy register and search any online provider before you part with money. If they are not listed, do not buy from them. Counterfeit Mounjaro pens are a documented and growing problem in the UK, with the MHRA seizing around 20 million doses of illegally traded weight-loss medicines worth approximately £45 million in 2025 alone.
A headline price for Mounjaro rarely tells the whole story. Across the private market, some providers charge separately for the initial consultation, others add a prescription fee on top, and delivery charges vary from free to £10 or more per order. Aftercare (the clinical support available between doses) is frequently not included at all, or limited to a single follow-up message.
Then there is the dose question. The licensed schedule starts at 2.5mg, which exists to give your system time to adjust, and titrates upward every four weeks as your prescriber agrees. The 5mg pen costs more than the starter dose, and prices step up further as the dose increases. If a provider quotes you an entry-level price, confirm what the cost becomes once you reach a therapeutic maintenance dose. The dose-by-dose picture matters for planning.
For those wondering whether the NHS route could reduce the cost, NHS access to Mounjaro is being phased in under NICE guidance but remains tightly restricted by BMI thresholds and the number of qualifying conditions, most people seeking private treatment do not currently meet those criteria. NICE's appraisal of tirzepatide, published as TA1026, sets out the NHS eligibility framework in full.
At nume, one transparent price covers the consultation, the prescription, the treatment itself, and free next-working-day delivery. There are no subscription arrangements and no auto-renewals, every repeat order is clinically re-reviewed before it goes out. We are not the cheapest option on the market, and that is a deliberate choice. Keeping clinical oversight, supply-chain integrity and aftercare properly resourced costs money.
What that means in practice: your consultation is read by a real prescriber, not processed by a scoring algorithm. A named pharmacist reviews your order. Medicines come through the licensed UK supply chain via authorised Eli Lilly routes. If you have questions between doses, our team is available seven days a week. You can read more about how we work or meet our clinical team before you decide.
Current treatment pricing is shown on our treatment page. We do not publish per-pen prices in body copy, because prices at the higher doses differ from the starter dose and we want you to see the full picture in context.
For a prescription-only medicine, the cheapest listing answers the wrong question. Price is a signal. A provider offering Mounjaro well below the market range, without clear evidence of GPhC registration, or a seller on social media offering it without any clinical assessment, is a significant warning sign, not a bargain.
The MHRA has issued repeated public warnings about fake weight-loss pens sold online. Counterfeit pens have contained insulin rather than tirzepatide, with serious consequences for people who used them. Report any suspect seller via the Yellow Card scheme. The right metric for a prescription weight-loss medicine is legitimate supply, proper clinical oversight and a pharmacy you can actually verify. If you are also considering whether a lower-cost route might suit you, our guide to alternatives covers what the evidence says. And if you want to understand how far the dose range extends, the upper end of the Mounjaro schedule has its own page.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.